PharmaCyte Biotech, Inc. (PMCB)

NASDAQ: PMCB · Real-Time Price · USD

0.5460

-0.0441 (-7.47%)

At close: Aug 10, 2026, 4:00 PM EDT

0.5512

+0.0052 (0.95%)

After-hours: Aug 10, 2026, 7:31 PM EDT

PharmaCyte Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 10, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Market Cap	6	8	8	17	2	2
Market Cap Growth	1.06%	-8.02%	-50.55%	942.43%	1.57%	10.70%
Enterprise Value	-31.22	-27.65	-7.11	-21.27	-66.41	-83.79
Last Close Price	0.55	0.72	1.24	2.12	2.92	2.33
PE Ratio	-	-	0.39	-	-	-
PB Ratio	0.19	0.23	0.16	0.62	0.02	0.02
P/TBV Ratio	0.14	0.18	0.18	0.78	0.02	0.01
EV/EBITDA Ratio	-	4.03	1.62	2.50	10.29	19.08
EV/EBIT Ratio	-	4.03	1.62	2.50	10.29	19.08
EV/FCF Ratio	-	5.37	2.39	9.89	17.50	20.35
Net Debt / Equity Ratio	-1.11	-1.11	-0.30	-1.81	-0.94	-0.95
Net Debt / EBITDA Ratio	5.41	5.41	3.55	5.89	10.54	19.45
Net Debt / FCF Ratio	7.20	7.20	5.22	23.32	17.93	20.74
Quick Ratio	45.16	45.16	6.60	6.76	115.99	121.24
Current Ratio	45.28	45.28	7.68	6.80	116.18	121.38
Return on Equity (ROE)	-54.31%	-44.72%	67.08%	0.59%	-5.31%	-8.78%
Return on Assets (ROA)	-13.34%	-13.45%	-7.61%	-12.79%	-7.88%	-8.96%
Return on Invested Capital (ROIC)	-28.48%	-29.77%	-18.96%	-116.77%	-125.86%	-85.63%
Return on Capital Employed (ROCE)	-13.66%	-13.96%	-8.36%	-13.61%	-7.94%	-9.09%
Earnings Yield	-	-	257.26%	-	-	-
Buyback Yield / Dilution	-14.31%	-14.31%	23.50%	-1751.81%	0.00%	-971.72%
Total Shareholder Return	-14.31%	-14.31%	23.50%	-1751.81%	0.00%	-971.72%

SEC Filings: 10-K · 10-Q